Video-EEG monitoring in diagnostics and treatment efficacy evaluation in newly-diagnosed generalized epilepsy in adults

Introduction. Video-electroencephalography (EEG) monitoring (VEEGM) is an indispensable functional method in epileptology. However, virtually no trials on assessing efficacy of antiepileptic drugs (AED) by using VEEGM are available.Objective: to improve efficacy of EEG-diagnostics and evaluate the e...

Full description

Bibliographic Details
Main Authors: A. B. Kozhokaru, V. A. Karlov, P. N. Vlasov, A. S. Orlova
Format: Article
Language:Russian
Published: IRBIS LLC 2021-04-01
Series:Эпилепсия и пароксизмальные состояния
Subjects:
Online Access:https://www.epilepsia.su/jour/article/view/653
_version_ 1797879351594713088
author A. B. Kozhokaru
V. A. Karlov
P. N. Vlasov
A. S. Orlova
author_facet A. B. Kozhokaru
V. A. Karlov
P. N. Vlasov
A. S. Orlova
author_sort A. B. Kozhokaru
collection DOAJ
description Introduction. Video-electroencephalography (EEG) monitoring (VEEGM) is an indispensable functional method in epileptology. However, virtually no trials on assessing efficacy of antiepileptic drugs (AED) by using VEEGM are available.Objective: to improve efficacy of EEG-diagnostics and evaluate the epileptiform activity index (EAI) in newly-diagnosed idiopathic generalized epilepsy in adult patients receiving  alproic acid and levetiracetam.Material and methods. T here w ere e nrolled 130 p atients: 6 0 (46.2%) m ales a nd 7 0 (53.8%) f emales w ith n ewlydiagnosedidiopathic generalized epilepsy (IGE), aged 22.51±8.9 years. All patients underwent VEEGM with quantitative EAI analysis at baseline visit and 1 3, 6 and 12 months later after treatment. Each seizure episode developed during the VEEGM study were assessed for type, time of seizure onset, relation to wake-sleep cycle, duration, ictal EEG pattern followed by diagnosing epileptic syndrome. Valproic acid and levetiracetam were used for initial therapy in groups per 65 patients in each. Treatment efficacy was assessed using parameters such as retention on therapy, absence of seizures, decrease of seizure frequency by >50%, decrease of seizure frequency by <50% – insufficient efficacy.Results. It was found that seizures during baseline VEEGM were recorded in 43.1% (n=56) patients, who were assigned to group 1, whereas remaining 74 (56.9%) patients were assigned to group 2. EAI was significantly higher in patients with seizures recoded at baseline VEEGM, compared to those lacking seizure episodes during initial VEEGM (p<0,001), mean EAI was also higher in group I at second (p<0.001) and third (p<0.001) visits. EAI magnitude at 6 and 12 months of study became virtually comparable in all groups and did not depend on AED prescribed. Treatment efficacy was higher in patients with IGE, with no  eizures recorded during the initial VEEGM.Conclusion. Long-term VEEGM allows unbiased assessment of treatment dynamics based on EAI analysis. The first 6 months of initial treatment titration in represent most crucial period for patients with newly-diagnosed IGE.
first_indexed 2024-04-10T02:46:20Z
format Article
id doaj.art-11c29b5b6b8b4e2dbf0932d8bfe2e839
institution Directory Open Access Journal
issn 2077-8333
2311-4088
language Russian
last_indexed 2024-04-10T02:46:20Z
publishDate 2021-04-01
publisher IRBIS LLC
record_format Article
series Эпилепсия и пароксизмальные состояния
spelling doaj.art-11c29b5b6b8b4e2dbf0932d8bfe2e8392023-03-13T07:44:18ZrusIRBIS LLCЭпилепсия и пароксизмальные состояния2077-83332311-40882021-04-01131213210.17749/2077-8333/epi.par.con.2021.046511Video-EEG monitoring in diagnostics and treatment efficacy evaluation in newly-diagnosed generalized epilepsy in adultsA. B. Kozhokaru0V. A. Karlov1P. N. Vlasov2A. S. Orlova3Russian State Research Center − Burnasyan Federal Medical Biophysical Center, Federal Medical Biological Agency; Central State Medical Academy of the Presidential Administration of the Russian FederationYevdokimov Moscow State University of Medicine and DentistryYevdokimov Moscow State University of Medicine and DentistrySechenov UniversityIntroduction. Video-electroencephalography (EEG) monitoring (VEEGM) is an indispensable functional method in epileptology. However, virtually no trials on assessing efficacy of antiepileptic drugs (AED) by using VEEGM are available.Objective: to improve efficacy of EEG-diagnostics and evaluate the epileptiform activity index (EAI) in newly-diagnosed idiopathic generalized epilepsy in adult patients receiving  alproic acid and levetiracetam.Material and methods. T here w ere e nrolled 130 p atients: 6 0 (46.2%) m ales a nd 7 0 (53.8%) f emales w ith n ewlydiagnosedidiopathic generalized epilepsy (IGE), aged 22.51±8.9 years. All patients underwent VEEGM with quantitative EAI analysis at baseline visit and 1 3, 6 and 12 months later after treatment. Each seizure episode developed during the VEEGM study were assessed for type, time of seizure onset, relation to wake-sleep cycle, duration, ictal EEG pattern followed by diagnosing epileptic syndrome. Valproic acid and levetiracetam were used for initial therapy in groups per 65 patients in each. Treatment efficacy was assessed using parameters such as retention on therapy, absence of seizures, decrease of seizure frequency by >50%, decrease of seizure frequency by <50% – insufficient efficacy.Results. It was found that seizures during baseline VEEGM were recorded in 43.1% (n=56) patients, who were assigned to group 1, whereas remaining 74 (56.9%) patients were assigned to group 2. EAI was significantly higher in patients with seizures recoded at baseline VEEGM, compared to those lacking seizure episodes during initial VEEGM (p<0,001), mean EAI was also higher in group I at second (p<0.001) and third (p<0.001) visits. EAI magnitude at 6 and 12 months of study became virtually comparable in all groups and did not depend on AED prescribed. Treatment efficacy was higher in patients with IGE, with no  eizures recorded during the initial VEEGM.Conclusion. Long-term VEEGM allows unbiased assessment of treatment dynamics based on EAI analysis. The first 6 months of initial treatment titration in represent most crucial period for patients with newly-diagnosed IGE.https://www.epilepsia.su/jour/article/view/653idiopathic epilepsygenetic generalized epilepsylong-term video-eeg monitoringepileptiform activity indexvalporic acidvalproatelevetiracetam
spellingShingle A. B. Kozhokaru
V. A. Karlov
P. N. Vlasov
A. S. Orlova
Video-EEG monitoring in diagnostics and treatment efficacy evaluation in newly-diagnosed generalized epilepsy in adults
Эпилепсия и пароксизмальные состояния
idiopathic epilepsy
genetic generalized epilepsy
long-term video-eeg monitoring
epileptiform activity index
valporic acid
valproate
levetiracetam
title Video-EEG monitoring in diagnostics and treatment efficacy evaluation in newly-diagnosed generalized epilepsy in adults
title_full Video-EEG monitoring in diagnostics and treatment efficacy evaluation in newly-diagnosed generalized epilepsy in adults
title_fullStr Video-EEG monitoring in diagnostics and treatment efficacy evaluation in newly-diagnosed generalized epilepsy in adults
title_full_unstemmed Video-EEG monitoring in diagnostics and treatment efficacy evaluation in newly-diagnosed generalized epilepsy in adults
title_short Video-EEG monitoring in diagnostics and treatment efficacy evaluation in newly-diagnosed generalized epilepsy in adults
title_sort video eeg monitoring in diagnostics and treatment efficacy evaluation in newly diagnosed generalized epilepsy in adults
topic idiopathic epilepsy
genetic generalized epilepsy
long-term video-eeg monitoring
epileptiform activity index
valporic acid
valproate
levetiracetam
url https://www.epilepsia.su/jour/article/view/653
work_keys_str_mv AT abkozhokaru videoeegmonitoringindiagnosticsandtreatmentefficacyevaluationinnewlydiagnosedgeneralizedepilepsyinadults
AT vakarlov videoeegmonitoringindiagnosticsandtreatmentefficacyevaluationinnewlydiagnosedgeneralizedepilepsyinadults
AT pnvlasov videoeegmonitoringindiagnosticsandtreatmentefficacyevaluationinnewlydiagnosedgeneralizedepilepsyinadults
AT asorlova videoeegmonitoringindiagnosticsandtreatmentefficacyevaluationinnewlydiagnosedgeneralizedepilepsyinadults